APA (7th ed.) Citation

Wang, H., Zhang, X., Zhao, X., Song, C., Deng, W., & Shen, W. (2024). Minimal residual disease guided radical chemoradiotherapy combined with immunotherapy after neoadjuvant immunochemotherapy followed by adjuvant immunotherapy for esophageal squamous cell cancer (ECMRD-001): A study protocol for a prospective cohort study. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Wang, Hesong, Xueyuan Zhang, Xiaohan Zhao, Chunyang Song, Wenzhao Deng, and Wenbin Shen. Minimal Residual Disease Guided Radical Chemoradiotherapy Combined with Immunotherapy After Neoadjuvant Immunochemotherapy Followed by Adjuvant Immunotherapy for Esophageal Squamous Cell Cancer (ECMRD-001): A Study Protocol for a Prospective Cohort Study. Frontiers Media S.A, 2024.

MLA (9th ed.) Citation

Wang, Hesong, et al. Minimal Residual Disease Guided Radical Chemoradiotherapy Combined with Immunotherapy After Neoadjuvant Immunochemotherapy Followed by Adjuvant Immunotherapy for Esophageal Squamous Cell Cancer (ECMRD-001): A Study Protocol for a Prospective Cohort Study. Frontiers Media S.A, 2024.